Department of Neurobiology and Research Institute for Aging and Medicine, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
National Clinical Research Center for Aging and Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Acta Pharmacol Sin. 2024 Dec;45(12):2487-2496. doi: 10.1038/s41401-024-01339-z. Epub 2024 Jul 11.
Brain microvascular endothelial cells (BMECs), an important component of the neurovascular unit, can promote angiogenesis and synaptic formation in ischaemic mice after brain parenchyma transplantation. Since the therapeutic efficacy of cell-based therapies depends on the extent of transplanted cell residence in the target tissue and cell migration ability, the delivery route has become a hot research topic. In this study, we investigated the effects of carotid artery transplantation of BMECs on neuronal injury, neurorepair, and neurological dysfunction in rats after cerebral ischaemic attack. Purified passage 1 endothelial cells (P1-BMECs) were prepared from mouse brain tissue. Adult rats were subjected to transient middle cerebral artery occlusion (MCAO) for 30 min. Then, the rats were treated with 5 × 10 P1-BMECs through carotid artery infusion or tail vein injection. We observed that carotid artery transplantation of BMECs produced more potent neuroprotective effects than caudal injection in MCAO rats, including reducing infarct size and alleviating neurological deficits in behavioural tests. Carotid artery-transplanted BMECs displayed a wider distribution in the ischaemic rat brain. Immunostaining for endothelial progenitor cells and the mature endothelial cell markers CD34 and RECA-1 showed that carotid artery transplantation of BMECs significantly increased angiogenesis. Carotid artery transplantation of BMECs significantly increased the number of surviving neurons, decreased the cerebral infarction volume, and alleviated neurological deficits. In addition, we found that carotid artery transplantation of BMECs significantly enhanced ischaemia-induced hippocampal neurogenesis, as measured by doublecortin (DCX) and Ki67 double staining within 2 weeks after ischaemic injury. We conclude that carotid artery transplantation of BMECs can promote cerebral angiogenesis, neurogenesis, and neurological function recovery in adult rats after ischaemic stroke. Our results suggest that carotid injection of BMECs may be a promising new approach for treating acute brain injuries.
脑微血管内皮细胞(BMEC)是神经血管单元的重要组成部分,在脑实质移植后可促进缺血小鼠的血管生成和突触形成。由于细胞疗法的治疗效果取决于移植细胞在靶组织中的居留程度和细胞迁移能力,因此输送途径已成为一个热门研究课题。在这项研究中,我们研究了颈动脉移植 BMEC 对脑缺血攻击后大鼠神经元损伤、神经修复和神经功能障碍的影响。从鼠脑组织中制备了纯化的第 1 代内皮细胞(P1-BMEC)。成年大鼠进行短暂性大脑中动脉闭塞(MCAO)30 分钟。然后,通过颈动脉输注或尾静脉注射将 5×10 P1-BMEC 处理大鼠。我们观察到,与 MCAO 大鼠的尾静脉注射相比,颈动脉移植 BMEC 产生了更强的神经保护作用,包括减少梗死面积和改善行为测试中的神经功能缺损。颈动脉移植的 BMEC 在缺血大鼠大脑中的分布更广泛。内皮祖细胞和成熟内皮细胞标志物 CD34 和 RECA-1 的免疫染色显示,颈动脉移植 BMEC 显著增加了血管生成。颈动脉移植的 BMEC 显著增加了存活神经元的数量,减少了脑梗死体积,并缓解了神经功能缺损。此外,我们发现颈动脉移植的 BMEC 显著增强了缺血诱导的海马神经发生,这可以通过缺血损伤后 2 周内双皮质素(DCX)和 Ki67 双重染色来衡量。我们得出结论,颈动脉移植 BMEC 可促进成年大鼠缺血性中风后大脑的血管生成、神经发生和神经功能恢复。我们的研究结果表明,颈动脉注射 BMEC 可能是治疗急性脑损伤的一种有前途的新方法。